Trials / Completed
CompletedNCT00813397
Manageability and Safety Assessment of Sepraspray in Abdominal Surgery.
Manageability and Safety Assessment of the SepraSpray Anti-adhesion Barrier in Abdominal Coelioscopic Surgery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 210 (actual)
- Sponsor
- Genzyme, a Sanofi Company · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will examine the performance of SeprasSpray in patients undergoing abdominal surgery (laparoscopic).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Sepraspray | Max. 10g of Sepraspray |
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2009-07-01
- Completion
- 2009-07-01
- First posted
- 2008-12-23
- Last updated
- 2015-05-22
Locations
15 sites across 1 country: France
Source: ClinicalTrials.gov record NCT00813397. Inclusion in this directory is not an endorsement.